Logo image of CDR

CEDAR REALTY TRUST INC (CDR) Stock Fundamental Analysis

NYSE:CDR - New York Stock Exchange, Inc. - US1506026053 - REIT - Currency: USD

29  +0.02 (+0.07%)

After market: 29 0 (0%)

Fundamental Rating

0

Overall CDR gets a fundamental rating of 0 out of 10. We evaluated CDR against 129 industry peers in the Diversified REITs industry. CDR may be in some trouble as it scores bad on both profitability and health. CDR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CDR has reported negative net income.
CDR Yearly Net Income VS EBIT VS OCF VS FCFCDR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M -20M 40M -40M

1.2 Ratios

Industry RankSector Rank
ROA -14.52%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CDR Yearly ROA, ROE, ROICCDR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 -5 -10

1.3 Margins

Industry RankSector Rank
OM 15.32%
PM (TTM) -179.36%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CDR Yearly Profit, Operating, Gross MarginsCDR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 20 -20 40 60

More info and screens

0

2. Health

2.1 Basic Checks

CDR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CDR has been increased compared to 1 year ago.
The debt/assets ratio for CDR has been reduced compared to a year ago.
CDR Yearly Shares OutstandingCDR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2M 4M 6M 8M 10M
CDR Yearly Total Debt VS Total AssetsCDR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M 1B

2.2 Solvency

A Debt/Equity ratio of 1.26 is on the high side and indicates that CDR has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC7.42%
CDR Yearly LT Debt VS Equity VS FCFCDR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 200M 400M 600M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

1

3. Growth

3.1 Past

CDR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -3993.41%.
The Revenue for CDR has decreased by -27.82% in the past year. This is quite bad
CDR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.33% yearly.
EPS 1Y (TTM)-3993.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%422.22%
Revenue 1Y (TTM)-27.82%
Revenue growth 3Y-5.68%
Revenue growth 5Y-3.33%
Sales Q2Q%-21.59%

3.2 Future

CDR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.64% yearly.
Based on estimates for the next years, CDR will show a decrease in Revenue. The Revenue will decrease by -3.81% on average per year.
EPS Next Y99.12%
EPS Next 2Y40.89%
EPS Next 3Y25.64%
EPS Next 5Y18.64%
Revenue Next Year-2.14%
Revenue Next 2Y-3.63%
Revenue Next 3Y-3.81%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CDR Yearly Revenue VS EstimatesCDR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CDR Yearly EPS VS EstimatesCDR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2 -4 -6 -8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

CDR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CDR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CDR Price Earnings VS Forward Price EarningsCDR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.82
CDR Per share dataCDR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

A more expensive valuation may be justified as CDR's earnings are expected to grow with 25.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.89%
EPS Next 3Y25.64%

More info and screens

1

5. Dividend

5.1 Amount

CDR has a yearly dividend return of 0.91%, which is pretty low.
Compared to an average S&P500 Dividend Yield of 2.40, CDR's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.91%

5.2 History

The dividend of CDR decreases each year by -41.52%.
CDR has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-41.52%
Div Incr YearsN/A
Div Non Decr YearsN/A
CDR Yearly Dividends per shareCDR Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 5 10 15

5.3 Sustainability

The earnings of CDR are negative and hence is the payout ratio. CDR will probably not be able to sustain this dividend level.
DP-9.77%
EPS Next 2Y40.89%
EPS Next 3Y25.64%
CDR Yearly Income VS Free CF VS DividendCDR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 0 20M -20M -40M

More info and screens

CEDAR REALTY TRUST INC

NYSE:CDR (8/22/2022, 8:04:20 PM)

After market: 29 0 (0%)

29

+0.02 (+0.07%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)08-04 2022-08-04/amc
Earnings (Next)11-02 2022-11-02
Inst Owners0%
Inst Owner Change0%
Ins Owners8.23%
Ins Owner Change-0.27%
Market Cap393.10M
Analysts76.67
Price Target29.58 (2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.91%
Yearly Dividend0.26
Dividend Growth(5Y)-41.52%
DP-9.77%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5
P/FCF N/A
P/OCF N/A
P/B 0.99
P/tB N/A
EV/EBITDA 19.82
EPS(TTM)-7.45
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS5.8
BVpS29.39
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.52%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 15.32%
PM (TTM) -179.36%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score3
WACC7.42%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3993.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%422.22%
EPS Next Y99.12%
EPS Next 2Y40.89%
EPS Next 3Y25.64%
EPS Next 5Y18.64%
Revenue 1Y (TTM)-27.82%
Revenue growth 3Y-5.68%
Revenue growth 5Y-3.33%
Sales Q2Q%-21.59%
Revenue Next Year-2.14%
Revenue Next 2Y-3.63%
Revenue Next 3Y-3.81%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A